Pavel Hamet, O.Q., MD, PhD, FRCPC, FAHA, FRSM, FCAHS
Dr. Hamet is the Canada Research Chair in Predictive Genomics. He is Professor of Medicine at Université de Montréal, Adjunct Professor of Experimental Medicine at McGill University, and Visiting Professor at the First Faculty of Medicine at Charles University, Prague, Czech Republic. He is currently Chief of Gene Medicine Services, member of the Endocrinology Service, and Director of the Ecogenomic Platform for Complex Diseases at the CHUM. He is also President of the International Society of Pathophysiology as well as Chief Scientific Officer of Medpharmgene. Author or co-author of over 575 scientific publications, Dr Hamet serves on many national and international boards including the Board of Directors of the Société Francophone du Diabète.
He has received many honours, including the prestigious Wilder Penfield Award in 2001. In 2008, Dr Hamet was named as an Officer of the Ordre national du Québec and received the Okamoto Award by the Japan Vascular Disease Research Foundation.
Since 2010, he is Associate Editor of the prestigious Journal of Hypertension. In 2011, He was named by the Council of Ministers of Quebec member of the Committee of Ethics in Science and in Technology.
In 2012, the Société Francophone du Diabète honoured him with the Roger Assan Award and in 2013 he received from the Centre de recherche du CHUM «le Prix Excellence» to underline his remarkable career.